collagenase-1 inhibitors (Affymax)

N/A

Report date: 2025/03/18 20:00:05

NME

Base Information

Drug Namecollagenase-1 inhibitors (Affymax)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMatrix metalloproteinase-1 inhibitors

TargetsMatrix metalloproteinase-1

Therapy Area/IndicationsArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAffymax Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAffymax Inc

Active IndicationsN/A

Inactive IndicationsArthritis, Rheumatoid

ATC CodeN/A